3-Methyl-1-(phenylsulfanyl)butan-2-one

Catalog No.: 
ACTNIL315
CAS No.: 
71221-49-3
Molecular Formula: 
C11H14OS
Molecular Weight: 
194.30
3-Methyl-1-(phenylsulfanyl)butan-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$209.00InquiryInquiry
100mg95%$304.00InquiryInquiry
250mg95%$426.00InquiryInquiry
1g95%$840.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-1-(phenylsulfanyl)butan-2-one
IUPAC Name3-methyl-1-(phenylthio)butan-2-one
MDL No.MFCD21105421
Molecular FormulaC11H14OS
Molecular Weight194.30
SMILESCC(C)C(CSC1=CC=CC=C1)=O
InChI KeyMZAUOCRPISRSTQ-UHFFFAOYSA-N
Synonym2-Butanone, 3-methyl-1-(phenylthio)-;3-methyl-1-(phenylthio)butan-2-one;3-methyl-1-(phenylsulfanyl)butan-2-one
CAS No.71221-49-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTNIL315 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGBIM039 route compound structure diagram
    ACGBIM03919967-55-6In Stock
  2. Plus
  3. ACBDXE076 route compound structure diagram
    --
  4. Then
  5. ACTNIL315 route product structure diagram
    ACTNIL31571221-49-3
Inquiry

2. ACTNIL315 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGADR261 route compound structure diagram
    ACGADR26117687-63-7
  2. Plus
  3. ACBDXE076 route compound structure diagram
    --
  4. Then
  5. ACTNIL315 route product structure diagram
    ACTNIL31571221-49-3
Inquiry

3. ACTNIL315 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDXE076 route compound structure diagram
    --
  2. Then
  3. ACTNIL315 route product structure diagram
    ACTNIL31571221-49-3
Inquiry

Comments (0)